Treatment of Pathologic Stage C Carcinoma of the Prostate with Adjuvant Radiotherapy

Economic evaluations in NCI-sponsored network cancer clinical trials

VT Nghiem;R Vaidya;GH Lyman;DL Hershman;SD Ramsey;JM Unger Value in Health Dec;23(12):1653-1661. doi: 10.1016/j.jval.2020.08.2095. Epub 2020 Oct 9

PMid: PMID33248521 | PMC number: PMC8262264

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial [PMID 19167731]

IM Thompson;CM Tangen;JC Paradelo;MS Lucia;GJ Miller;DA Troyer;EM Messing;JD Forman;JL Chin;GP Swanson;ED Canby-Hagino;ED Crawford Journal of Urology 181(3):956-962

Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): research objectives workshop 2008 [PMID19723641; PMC2978526]

P Okunieff;LA Kachnic;LS Constine;CD Fuller;LE Gaspar;DF Hayes;J Hooks;C Ling;FL Meyskens;PA Philip;D Raben;SR Smalley;GP Swanson;BA Teicher;CR Thomas;B Vikram;MJ Zelefsky;LH Baker Clinical Cancer Research 15(18):5663-5770

Lack of low-risk pathologic findings in SWOG 8794

G Swanson;B Goldman;C Tangen;IM Thompson;J Chin;E Messing;E Canby-Higano;J Forman;E Crawford International Journal of Radiation Oncology, Biology & Physics 75(S):abst #20, S10, 2009 (oral pres., ASTRO)

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation in those patients: data from SWOG 8794 [PMID18930488]

GP Swanson;B Goldman;CM Tangen;JL Chin;EM Messing;ED Canby-Higino;JD Forman;IM Thompson;ED Crawford Journal of Urology 180:2453-2457

Adjuvant radiotherapy for pT3 for prostate cancer: results of a randomized, prospective clinical trial, 2008 update

GP Swanson;IM Thompson;C Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;F Miller;MS Lucia;JD Forman;J Chin;EM Messing American Urological Assn Annual Meeting, "late breaking" presentation

Updated results of SWOG 8794: adjuvant radiation for high risk prostate cancer

GP Swanson;IM Thompson;CM Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;MS Lucia;JD Forman;JL Chin;EM Messing Radiotherapy and Oncology 88(S2):S148(449)

Prognostic significance of pathologic SV involvement and the effect of adjuvant radiation therapy on outcome

GP Swanson;IM Thompson;B Goldman;CM Tangen;JL Chin;EM Messing;ED Canby-Hagino;JD Forman;ED Crawford Radiotherapy and Oncology 88(S2):S337(1057)

Update of SWOG 8794: adjuvant radiotherapy of pT3 prostate cancer improves metastasis free survival

GP Swanson;IM Thompson;CM Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;GJ Miller;MS Lucia;JD Forman;JL Chin International Journal of Radiation Oncology Biology Physics 72(1)suppl. 1:S31

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 [PMID17538167]

GP Swanson;MA Hussey;CM Tangen;J Chin;E Messing;E Canby-Higano;JD Foreman;IM Thompson;ED Crawford Journal of Clinical Oncology 25(16):2225-2229

Adjuvant radiotherapy for pathologically-advanced prostate cancer: a randomized, clinical trial

IM Thompson;CM Tangen;J Paradelo;MS Lucia;G Miller;D Troyer;E Messing;J Forman;J Chin;G Swanson;E Canby-Hagino;ED Crawford Journal of the American Medical Association 296(19):2329-2335

Pre radiation PSA predicts for outcome of adjuvant radiation in SWOG 8794

GP Swanson;MA Hussey;IM Thompson;ED Crawford Proc of the AUA, Journal of Urology 175(4) Suppl:216 (#668)

Adjuvant radiotherapy for pathologic T3 prostate cancer: results of a randomized, prospective clinical trial with metastasis-free survival endpoint

IM Thompson;C Tangen;G Miller;MS Lucia;D Troyer;J Paradelo;J Chin;E Messing;E Canby-Hagino;J Forman;ED Crawford Journal of Urology 173(4):451 (#1665)

Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794)

G Swanson;I Thompson;C Tangen;G Miller;MS Lucia;D Troyer;J Paradelo;J Chin;E Messing;E Canby-Hagino;J Forman;ED Crawford Proc ASTRO, Int J Radiat Oncol Biol Phy 63 (Suppl 1):S1 (#1), 2005.

An opportunity to determine optimal treatment of pT3 prostate cancer: The window may be closing

IM Thompson;JC Paradelo;ED Crawford;CA Coltman;B Blumenstein Urology 44(6):804-811

Adjuvant radiotherapy following radical prostatectomy for pathologic stage C adenocarcinoma of the prostate: Initial evaluation of toxicity.

I Thompson;ED Crawford;G Miller;J Paradelo;B Blumenstein;M Wolf;C Moinpour;K Hayden ASCO 11:212(#663)